[KROS] QoQ Quarter Result on 30-Sep-2020 [#Q3]

Stock
[KROS] Keros Therapeutics, Inc.
Announcement Date
10-Nov-2020
Financial Year
2020
Quarter
30-Sep-2020 [#Q3]
Profit Trend
QoQ- -11.89%
YoY- -239.14%
Quarter Report
KROS's Result
KROS's Financial Summary
View:
Show?
Quarter Result
30/06/21 31/03/21 31/12/20 30/09/20 30/06/20 31/03/20 31/12/19 CAGR
Revenue 100 0 0 2,500 2,500 2,500 2,500 -88.32%
PBT -15,622 -15,835 -10,676 -12,036 -10,757 -12,064 -2,751 218.63%
Tax -79 50 82 -156 1 -172 2,302 -
NP -15,622 -15,885 -10,676 -12,036 -10,757 -11,892 -2,751 218.63%
Tax Rate - - - - - - - -
Total Cost 15,722 15,885 10,676 14,536 13,257 14,392 5,251 107.87%
Ratio Analysis
30/06/21 31/03/21 31/12/20 30/09/20 30/06/20 31/03/20 31/12/19 CAGR
NP Margin -15,622.00 0.00 0.00 -481.44 -430.28 -475.68 -110.04 2629.62%
Per Share
30/06/21 31/03/21 31/12/20 30/09/20 30/06/20 31/03/20 31/12/19 CAGR
EPS -0.67 -0.68 -0.49 -0.60 -0.61 -0.65 -0.31 67.24%
EPS Diluted -0.67 -0.68 -0.49 -0.60 -0.61 -0.65 -0.31 67.24%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.